3.23
-0.04 (-1.22%)
-0.04 (-1.22%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Catalyst Pharmaceuticals Inc | CPRX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.04 | -1.22% | 3.23 | 09:58:38 |
| Close Price | Low Price | High Price | Open Price | Previous Close |
|---|---|---|---|---|
| 3.22 | 3.30 | 3.27 | 3.27 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 3.22 | 3.23 | 0.01 | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 846 | 119,804 | $ 3.25 | $ 389,078 | 2,250,333 | 2.55 - 6.6251 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 09:58:38 | 7 | $ 3.23 | USD |
Catalyst Pharmaceuticals Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 338.33M | 103.46M | 96.19M | $ 102.31M | $ 35.79M | 0.29 | 8.20 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Catalyst Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CPRX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.36 | 3.49 | 3.14 | 3.33 | 1,601,475 | -0.13 | -3.87% |
| 1 Month | 3.36 | 3.49 | 2.96 | 3.26 | 1,568,460 | -0.13 | -3.87% |
| 3 Months | 4.57 | 5.24 | 2.96 | 3.85 | 1,863,557 | -1.34 | -29.32% |
| 6 Months | 2.99 | 5.24 | 2.85 | 4.15 | 1,886,018 | 0.24 | 8.03% |
| 1 Year | 6.62 | 6.6251 | 2.55 | 4.30 | 2,095,075 | -3.39 | -51.21% |
| 3 Years | 2.42 | 7.67 | 1.85 | 3.99 | 1,614,483 | 0.81 | 33.47% |
| 5 Years | 4.11 | 7.67 | 0.51 | 3.38 | 1,306,528 | -0.88 | -21.41% |
Catalyst Pharmaceuticals Description
| Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing innovative therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with lambert-eaton myasthenic syndrome. |
